OQS
CDLX icon

Occudo Quantitative Strategies’s Cardlytics CDLX Stock Holding History

Occudo Quantitative Strategies’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,648
Closed -$244K – 769
2023
Q4 		$244K Buy
+2,648
New +$269K 0.03% 596
2023
Q2 		– Sell
-4,780
Closed -$162K – 1043
2023
Q1 		$162K Sell
4,780
-2,834
-37% -$148K 0.01% 777
2022
Q4 		$440K Sell
7,614
-524
-6% -$32.4K 0.05% 545
2022
Q3 		$765K Buy
8,138
+4,538
+126% +$646K 0.06% 517
2022
Q2 		$803K Buy
+3,600
New +$1.21M 0.07% 453

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Occudo Quantitative Strategies's CDLX Position: Q1 2024 in Review

Occudo Quantitative Strategies sold out of Cardlytics (CDLX) in Q1 2024, closing a stake of 2,648 shares — an estimated $244K sold.

Occudo Quantitative Strategies first reported a position in CDLX in Q2 2022 and held it in 5 quarters. The position peaked at $803K in Q2 2022. 144 funds tracked by Wall St. Rank hold CDLX as of Q1 2024.

  • Occudo Quantitative Strategies reported no remaining Cardlytics position as of Q1 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 2,648 Cardlytics shares in Q1 2024, an estimated $244K.
  • Occudo Quantitative Strategies first reported a position in Cardlytics in Q2 2022 and held it in 5 quarters.
  • Occudo Quantitative Strategies's Cardlytics position peaked at $803K in Q2 2022.
  • 144 funds tracked by Wall St. Rank held Cardlytics as of Q1 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2024, filed 15 May 2024.